As other players have moved out of the vaccines business, it has become more interesting for others to go in. The manufacturers that are left gain a lot of pricing power, and interest has also risen in the face of pandemic risks.
European pharmaceuticals have outperformed quite considerably over the last year or so. Fundamentally, they should continue doing better in 2006.
I don't think people have really modeled in the generics acquisitions yet. The generics acquisition isn't something that has been seen positively yet.
I don't think people have really modeled in the generics acquisitions yet. The generics acquisition isn't something that has been seen positively yet. The shares have performed a bit better since the research and development day.
Their products are quite unique. The figures were strong.
Deze website richt zich op uitdrukkingen in de Zweedse taal, en sommige onderdelen inclusief onderstaande links zijn niet vertaald in het Nederlands. Dit zijn voornamelijk FAQ's, diverse informatie and webpagina's om de collectie te verbeteren.
Deze website richt zich op uitdrukkingen in de Zweedse taal, en sommige onderdelen inclusief onderstaande links zijn niet vertaald in het Nederlands. Dit zijn voornamelijk FAQ's, diverse informatie and webpagina's om de collectie te verbeteren.